alcoholic pancreatitis: Acute or chronic inflammation of the pancreas due to excessive alcohol drinking. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1312 |
4. Check minimum number of eventsNone |
1312 |
5. Include endpointsNone |
1312 |
6. Filter based on genotype QC (FinnGen only) |
1312 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K85
Similar endpoints
↥List of similar endpoints to
Alcohol-induced acute pancreatitis
based on the number of shared cases.
Similar with more cases:
- Acute pancreatitis
- Acute pancreatitis (for exclusion)
- Alcohol use disorder, Swedish definition
- Alcohol related diseases, tilastokeskus definition
- Alcohol related diseases and deaths, all endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13938 | 2274 | 11487 |
| Only index persons | 9836 | 1787 | 8049 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.28 | 0.07 | 0.32 |
| Only index persons | 0.26 | 0.07 | 0.31 |
| Median age at first event (years) | |||
| Whole population | 45.74 | 48.04 | 45.21 |
| Only index persons | 46.50 | 48.71 | 46.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1312 | 242 | 1070 |
| Unadjusted period prevalence (%) | 0.40 | 0.08 | 0.47 |
| Median age at first event (years) | 48.87 | 48.67 | 48.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1168
- Matched controls
- 11680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
5770D
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]
+∞
323.0
445
*
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
16384.0
323.0
711
*
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
120.6
323.0
462
63
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
59.3
319.7
374
92
K85
ICD-10 Finland
Acute pancreatitis
38.7
190.8
244
79
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
10.9
190.4
408
550
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
135.8
183.6
193
17
JN3AD
NOMESCO Finland
Abdominal CT examination
10.5
164.7
353
461
K86.1
ICD-10 Finland
Other chronic pancreatitis
66.4
160.8
185
33
JN3BD
NOMESCO Finland
Extensive abdominal CT
8.4
157.9
397
675
A09AA02
ATC
multienzymes (lipase, protease etc.)
26.9
142.3
200
89
K86.3
ICD-10 Finland
Pseudocyst of pancreas
102.7
140.0
152
17
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
93.4
133.8
147
18
R10.1
ICD-10 Finland
Pain localized to upper abdomen
6.3
123.2
383
839
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
30.1
122.2
166
64
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.1
106.0
596
2371
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
104.9
364
887
P15
ICPC
Chronic alcohol abuse
12.1
103.9
199
195
N07BB01
ATC
disulfiram; oral
8.1
100.0
245
372
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.8
99.8
279
514
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
12.4
95.6
180
169
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
27.5
93.6
130
53
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
150.9
92.6
97
7
5770F
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]
335.2
92.2
92
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
14.9
87.7
151
115
N02AX02
ATC
tramadol; systemic, rectal
3.4
84.0
702
3607
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
205.8
75.1
77
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
11.2
73.0
143
143
A10AE04
ATC
insulin glargine; parenteral
4.9
72.8
268
665
N05CF01
ATC
zopiclone; oral
3.2
70.8
506
2224
103
Kela drug reimbursment
Diabetes, insulin-treated
3.2
69.8
495
2160
N05BA01
ATC
diazepam; systemic, rectal
4.3
69.7
298
857
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.4
69.0
229
504
N06AX11
ATC
mirtazapine; oral
3.2
68.6
508
2278
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
12.3
68.4
128
116
N05AH04
ATC
quetiapine; oral
3.9
67.9
328
1052
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
15.7
67.6
113
79
F10.24
ICD-10 Finland
Alcohol depence active use
13.7
65.0
115
92
K85.8
ICD-10 Finland
Other acute pancreatitis
29.9
60.1
81
29
F10.09
ICD-10 Finland
Alcohol intoxication UNS
10.4
59.7
121
128
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
57.8
370
1457
A02BC02
ATC
pantoprazole; systemic
2.8
57.0
847
5643
N05BA04
ATC
oxazepam; oral
3.2
56.2
368
1467
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
56.0
436
1955
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
53.7
435
1988
P16
ICPC
Acute alcohol abuse
11.5
52.8
101
95
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
51.4
313
1172
5770E
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICAHAEMORRHAGICA]
+∞
50.4
48
*
R10.0
ICD-10 Finland
Acute abdomen
9.7
49.7
104
116
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
9.8
49.5
103
114
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
12.1
49.3
92
82
N05BA02
ATC
chlordiazepoxide; systemic
7.8
48.5
116
162
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.3
48.3
121
181
N06AB04
ATC
citalopram; systemic
3.0
47.9
336
1380
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
35.7
47.4
61
18
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
46.7
297
1136
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
13.1
44.8
80
65
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.4
44.7
143
294
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
26.7
44.1
61
24
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.7
43.9
217
683
K92.0
ICD-10 Finland
Haematemesis
8.6
43.7
98
123
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
43.2
606
3644
N05CD07
ATC
temazepam; oral
3.6
43.1
222
721
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.7
43.1
130
249
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.6
42.3
84
85
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
10.3
42.3
85
88
T90
ICPC
Diabetes non-insulin dependent
2.7
42.1
376
1768
K70.1
ICD-10 Finland
Alcoholic hepatitis
17.7
40.6
64
38
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
40.3
367
1739
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.5
39.7
123
243
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
38.6
396
1994
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
12.3
38.2
70
60
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
9.2
37.8
81
94
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
13.6
37.8
66
51
Z72.1
ICD-10 Finland
Alcohol use
10.5
37.7
75
76
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
12.4
37.2
68
58
UJK02
NOMESCO Finland
ERCP
8.2
35.9
82
106
TKC20
NOMESCO Finland
Catheterisation of bladder
4.1
35.8
152
415
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
35.0
239
938
K86.8
ICD-10 Finland
Other specified diseases of pancreas
127.2
34.9
37
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
19.1
34.7
53
29
K29.2
ICD-10 Finland
Alcoholic gastritis
40.5
34.5
43
11
N05AB01
ATC
dixyrazine; systemic
10.0
34.4
70
74
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
6.6
33.3
89
145
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.0
33.1
95
170
WX892
NOMESCO Finland
Monitored bed care
3.7
32.2
153
459
C07AA05
ATC
propranolol; systemic
2.7
32.0
261
1136
D02
ICPC
Abdominal pain epigastric
5.0
31.4
106
230
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.6
31.3
260
1144
N06AB10
ATC
escitalopram; oral
2.6
31.1
266
1187
ZXD05
NOMESCO Finland
Urgent procedure
2.2
31.1
416
2335
Z2446
NOMESCO Finland
Social worker
4.1
30.5
125
329
R4110
NOMESCO Finland
Physiotherapy
2.3
30.2
355
1867
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
11.0
30.2
58
55
T89
ICPC
Diabetes insulin dependent
5.2
30.1
98
204
N03AX16
ATC
pregabalin; oral
2.3
29.7
323
1635
ZXE00
NOMESCO Finland
One hour or less
2.1
29.5
477
2889
N06AX16
ATC
venlafaxine; oral
2.9
29.5
206
814
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.4
29.0
154
504
A06AD11
ATC
lactulose; oral
2.9
28.7
198
773
V03AA01
ATC
NA
5.8
28.6
83
151
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.5
28.4
141
437
A02BA02
ATC
ranitidine; systemic
2.5
27.9
266
1254
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
43.7
27.8
34
8
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
102.6
27.8
30
*
A10BA02
ATC
metformin; oral
2.1
27.7
392
2231
E13
ICD-10 Finland
Other specified diabetes mellitus
26.1
27.6
38
15
K85.1
ICD-10 Finland
Biliary acute pancreatitis
21.7
27.5
40
19
SPAT1265
SPAT
Breathalyser
10.4
27.4
54
54
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
27.4
173
638
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
16.3
27.4
44
28
E13.7
ICD-10 Finland
Other specified diabetes mellitus, with multiple complications
277.1
26.8
27
*
5770A
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]
46.9
26.6
32
7
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.9
26.4
76
137
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
26.4
684
4913
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
74.4
25.9
29
*
D01
ICPC
Abdominal pain/cramps general
3.3
25.7
139
460
N02BE01
ATC
paracetamol; systemic, rectal
2.3
25.6
989
8267
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.9
25.3
165
619
N06AB03
ATC
fluoxetine; oral
2.8
24.9
180
719
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
24.6
307
1636
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
4.5
24.1
88
207
N06AA12
ATC
doxepin; systemic
4.1
24.1
99
261
AA1AD
NOMESCO Finland
CT of head and brain
2.2
24.1
308
1656
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
6.9
24.0
61
93
Z3226
NOMESCO Finland
Physiotherapist
2.3
24.0
245
1188
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
23.9
437
2719
K86.0
ICD-10 Finland
Alcohol-induced chronic pancreatitis
68.9
23.9
27
*
J01DB01
ATC
cefalexin; oral
2.1
23.7
955
7927
JLC50
NOMESCO Finland
Atypical pancreatectomy
127.6
23.7
25
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
8.2
23.6
53
67
N05CF02
ATC
zolpidem; oral
2.4
23.4
230
1090
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.4
23.3
62
101
K92.1
ICD-10 Finland
Melaena
3.9
23.3
99
269
K70.0
ICD-10 Finland
Alcoholic fatty liver
12.8
23.2
41
33
R11
ICD-10 Finland
Nausea and vomiting
3.7
23.2
105
301
5772A
ICD-9 Finland
Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]
55.2
23.1
27
5
C03CA01
ATC
furosemide; systemic
2.1
22.8
312
1724
Z2221
NOMESCO Finland
Medical doctor
2.1
22.4
323
1822
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
22.3
349
2033
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
11.8
21.8
40
35
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
10.1
21.7
43
44
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.5
21.6
106
325
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.7
21.5
50
67
5353A
ICD-9 Finland
Gastritis and duodenitis, Alcoholic gastritis
51.0
21.2
25
5
A02BC05
ATC
esomeprazole; systemic
1.9
21.1
472
3121
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
19.9
20.9
31
16
WX002
NOMESCO Finland
Sedation and analgesia
2.2
20.4
250
1305
Z3231
NOMESCO Finland
Registered nurse
2.0
20.4
335
1975
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
20.4
562
3975
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.6
20.4
155
638
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.8
20.2
88
244
A02BC01
ATC
omeprazole; systemic
2.0
20.2
330
1942
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
20.1
112
376
EBA00
NOMESCO Finland
Extraction of tooth
1.9
20.0
412
2638
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.3
19.8
76
188
A03DA02
ATC
pitofenone and analgesics; systemic
9.6
19.7
40
43
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
19.6
137
534
JLB35
NOMESCO Finland
Transduodenal endoscopic extraction of foreign body from pancreatic duct
106.8
19.6
21
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
7.1
19.6
48
70
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
19.6
105
344
N05BE01
ATC
buspirone; oral
4.7
19.3
67
150
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
15.1
19.0
31
21
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
18.9
429
2823
S01.0
ICD-10 Finland
Open wound of scalp
2.8
18.8
132
515
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
7.6
18.8
44
60
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
13.7
18.8
32
24
5771C
ICD-9 Finland
Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA RECIDIVANS]
101.7
18.6
20
*
S06.0
ICD-10 Finland
Concussion
2.6
18.5
144
599
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
18.5
250
1358
SPAT1262
SPAT
Handing over of treatment supplies
2.1
18.5
248
1342
F51.0
ICD-10 Finland
Nonorganic insomnia
2.5
18.4
160
707
N05AA02
ATC
levomepromazine; systemic
3.4
18.3
90
276
C08CA01
ATC
amlodipine; oral
1.8
18.3
411
2687
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
8.5
18.0
39
47
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.4
18.0
91
285
SPAT1227
SPAT
Substance abuse rehabilitation
10.9
18.0
34
32
W19
ICD-10 Finland
Unspecified fall
2.6
17.7
136
561
5770C
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]
182.6
17.6
18
*
P01AB01
ATC
metronidazole; oral, rectal
1.8
17.5
407
2683
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.8
17.5
44
67
K86.2
ICD-10 Finland
Cyst of pancreas
13.4
17.5
30
23
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
29.3
17.5
23
8
N05BA12
ATC
alprazolam; oral
2.5
17.4
143
611
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.0
17.4
39
50
UJD02
NOMESCO Finland
Gastroscopy
3.8
17.4
75
207
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
8.3
17.3
38
47
N03AX12
ATC
gabapentin; oral
2.2
17.0
189
941
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
7.4
16.9
40
56
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
7.4
16.9
40
56
J01MA12
ATC
levofloxacin; systemic
2.0
16.8
243
1352
SPAT1254
SPAT
Administration of medicine
2.3
16.7
162
756
N06AB06
ATC
sertraline; oral
2.5
16.5
136
583
N02AA05
ATC
oxycodone; systemic
2.2
16.5
175
851
N07BA03
ATC
varenicline; oral
3.0
16.5
98
343
57709
ICD-8 Finland
Diseases of pancreas, Pancreatitis NUD
23.4
16.5
23
10
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.4
16.3
49
94
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
11.4
16.3
30
27
N05AH03
ATC
olanzapine; systemic
3.1
16.3
94
325
A10AE05
ATC
insulin detemir; parenteral
3.0
16.3
95
331
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
15.6
16.2
26
17
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.2
16.2
62
154
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.7
15.9
54
119
A10AE06
ATC
insulin degludec; parenteral
4.2
15.9
61
152
N06AX03
ATC
mianserin; oral
3.5
15.8
74
219
JAH33
NOMESCO Finland
Opening of laparostomy
33.9
15.8
20
6
F41.09
ICD-10 Finland
UNS Panic Syndrome
5.3
15.7
48
94
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
4.6
15.7
55
125
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
15.7
204
1084
S22.3
ICD-10 Finland
Fracture of rib
2.6
15.6
115
463
N06AA09
ATC
amitriptyline; systemic
2.5
15.6
126
532
Z71.8
ICD-10 Finland
Other specified counselling
1.9
15.3
243
1394
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.1
15.3
59
148
WX882
NOMESCO Finland
High dependency care
4.4
15.3
55
129
WX730
NOMESCO Finland
Conventional respirator
6.2
15.1
40
66
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
15.1
174
879
P01
ICPC
Feeling anxious/nervous/tense
2.8
15.1
101
385
E87.6
ICD-10 Finland
Hypokalaemia
4.4
15.0
55
131
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.1
14.9
182
940
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
32.1
14.8
19
6
D10
ICPC
Vomiting
3.6
14.7
67
194
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
14.6
453
3209
SPAT1247
SPAT
Outpatient detoxication and monitoring
11.0
14.5
27
25
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.4
14.5
71
218
N03AF01
ATC
carbamazepine; oral, rectal
3.2
14.5
78
257
5770B
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA HAEMORRHAGICA]
151.8
14.5
15
*
WYA20
NOMESCO Finland
Home visit
7.7
14.5
33
44
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
14.3
223
1266
A41.9
ICD-10 Finland
Sepsis, unspecified
3.6
14.3
64
183
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
8.8
14.3
30
35
WX872
NOMESCO Finland
Intensive care
2.8
14.3
92
342
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
9.3
14.2
29
32
P76
ICPC
Depressive disorder
3.2
14.2
77
255
B01AB05
ATC
enoxaparin; parenteral
1.8
14.1
327
2121
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
14.1
114
482
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.3
14.0
42
81
K70.4
ICD-10 Finland
Alcoholic hepatic failure
10.2
14.0
27
27
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
13.9
187
1001
A10BH01
ATC
sitagliptin; oral
2.3
13.9
134
620
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.3
13.9
71
226
E86
ICD-10 Finland
Volume depletion
5.0
13.8
44
91
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
13.5
430
3053
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
13.0
13.4
23
18
JAH00
NOMESCO Finland
Laparotomy
4.3
13.3
49
118
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.7
13.3
91
352
S18
ICPC
Laceration/cut
1.6
13.2
458
3321
N06AX05
ATC
trazodone; oral
4.6
13.1
45
101
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.5
13.1
61
181
M54.5
ICD-10 Finland
Low back pain
1.7
13.1
348
2346
WX110
NOMESCO Finland
Local anesthesy
1.6
13.0
754
6216
F32
ICD-10 Finland
Depressive episode
3.3
13.0
66
209
P03
ICPC
Feeling depressed
2.7
13.0
93
369
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.7
13.0
57
161
R53
ICD-10 Finland
Malaise and fatigue
1.9
12.9
207
1185
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.3
12.8
122
561
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
12.8
145
722
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.2
12.7
66
213
J01DA01
ATC
[U] cefalexin; systemic
1.6
12.6
670
5386
WX402
NOMESCO Finland
General anaesthesia
1.9
12.5
195
1103
JLT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pancreatic duct
+∞
12.5
12
*
E13.3
ICD-10 Finland
Other specified diabetes mellitus, with ophthalmic complications
+∞
12.5
12
*
N06AX21
ATC
duloxetine; oral
2.3
12.5
125
589
A01
ICPC
Pain general/multiple sites
2.7
12.5
85
327
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
12.4
112
501
T74.1
ICD-10 Finland
Physical abuse
5.7
12.4
35
63
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
12.4
268
1697
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
6.3
12.3
32
52
P18
ICPC
Medication abuse
9.8
12.3
24
25
A02BC03
ATC
lansoprazole; oral
1.7
12.2
313
2080
X57
ICD-10 Finland
Unspecified privation
4.3
12.2
45
109
K83.1
ICD-10 Finland
Obstruction of bile duct
6.5
12.2
31
49
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
12.2
86
336
TK800
NOMESCO Finland
Hemodialysis
3.9
12.1
49
129
A10BB12
ATC
glimepiride; oral
2.5
12.1
97
410
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
12.1
57
171
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.5
12.1
57
171
Z72.8
ICD-10 Finland
Other problems related to lifestyle
18.3
12.1
18
10
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
12.0
126
607
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
12.0
76
281
M79.6
ICD-10 Finland
Pain in limb
1.6
11.9
352
2429
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
11.9
124
597
E13.1
ICD-10 Finland
Other specified diabetes mellitus, with ketoacidosis
47.2
11.9
14
*
L17
ICPC
Foot/toe symptom/complaint
1.8
11.9
245
1523
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
14.8
11.8
19
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
11.8
138
698
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
11.8
423
3071
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.6
11.7
53
154
W10
ICD-10 Finland
Fall on and from stairs and steps
2.9
11.7
69
244
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
12.7
11.6
20
16
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
12.7
11.6
20
16
E13.4
ICD-10 Finland
Other specified diabetes mellitus, with neurological complications
65.6
11.6
13
*
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.3
11.6
114
534
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
11.6
230
1412
P74
ICPC
Anxiety disorder/anxiety state
3.9
11.4
46
121
TK810
NOMESCO Finland
Hemofiltration
8.0
11.4
25
32
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
11.3
97
425
M04AA01
ATC
allopurinol; systemic
1.9
11.1
170
956
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.1
11.1
24
30
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
8.1
11.1
24
30
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
7.2
11.1
26
37
N06AB05
ATC
paroxetine; oral
2.6
11.1
80
319
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.9
11.0
35
73
SPAT1240
SPAT
Therapeutic discussion
2.2
10.9
110
520
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
6.0
10.9
29
49
WX290
NOMESCO Finland
Other blockade of nerve
1.5
10.9
487
3711
2500X
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]
15.7
10.8
17
11
JN4AD
NOMESCO Finland
Body CT examination
2.3
10.7
101
464
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
10.7
117
575
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
60.6
10.6
12
*
5771D
ICD-9 Finland
Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA NUD]
60.6
10.6
12
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
11.3
10.6
19
17
309
Kela drug reimbursment
Nalmefene and naltrexone
8.6
10.6
22
26
C03DA01
ATC
spironolactone; oral
2.1
10.5
120
601
N17.8
ICD-10 Finland
Other acute renal failure
6.9
10.4
25
37
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
10.4
124
632
G72.8
ICD-10 Finland
Other specified myopathies
5.0
10.4
32
65
57708
ICD-8 Finland
Diseases of pancreas, Pancreatitis acuta alia
16.2
10.4
16
10
2918A
ICD-9 Finland
Alcoholic psychoses, Other specified alcoholic psychosis
12.2
10.4
18
15
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
8.9
10.3
21
24
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
9.7
10.3
20
21
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
19.0
10.3
15
8
ZXD35
NOMESCO Finland
Usual procedure
3.0
10.2
58
198
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
10.2
71
275
N05AF03
ATC
chlorprothixene; systemic
3.6
10.2
45
129
K02.1
ICD-10 Finland
Caries of dentine
1.5
10.2
608
4911
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
10.2
286
1936
K29.7
ICD-10 Finland
Gastritis, unspecified
3.4
10.1
48
146
S97
ICPC
Chronic ulcer skin
2.7
10.0
70
273
JN4BD
NOMESCO Finland
Extensive body CT
2.0
10.0
133
707
K29.1
ICD-10 Finland
Other acute gastritis
5.9
10.0
27
47
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
16.9
9.9
15
9
F34.1
ICD-10 Finland
Dysthymia
3.3
9.9
48
149
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.2
9.8
51
166
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.8
340
2426
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
9.8
84
367
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
9.7
90
410
ZXA00
NOMESCO Finland
Right side
1.6
9.6
271
1831
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
9.6
89
407
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
7.2
9.5
22
31
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.7
9.5
63
239
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
5.0
9.5
29
59
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.6
9.4
21
28
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
9.4
191
1174
JAH30
NOMESCO Finland
Laparostomy
100.8
9.4
10
*
E13.2
ICD-10 Finland
Other specified diabetes mellitus, with renal complications
100.8
9.4
10
*
RS221
NOMESCO Finland
NA
5.2
9.4
28
55
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
6.3
9.4
24
39
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.4
9.4
27
51
C07AB07
ATC
bisoprolol; oral
1.5
9.3
489
3817
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.6
9.3
41
118
E87.2
ICD-10 Finland
Acidosis
8.8
9.3
19
22
RS222
NOMESCO Finland
NA
5.5
9.2
26
48
L86
ICPC
Back syndrome with radiating pain
2.5
9.2
69
282
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
9.2
290
2016
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
4.1
9.2
34
84
JLC10
NOMESCO Finland
Distal pancreatectomy
13.8
9.2
15
11
UJF32
NOMESCO Finland
Coloscopy
1.6
9.1
261
1770
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
9.1
57
208
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.8
9.1
57
208
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
9.1
141
792
N05AD03
ATC
melperone; systemic
5.7
9.1
25
45
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
9.1
170
1019
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
9.0
141
797
N19
ICD-10 Finland
Unspecified kidney failure
3.3
9.0
43
132
N06AA06
ATC
trimipramine; systemic
3.7
9.0
38
106
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.8
8.9
24
42
P19
ICPC
Drug abuse
8.0
8.9
19
24
J96.0
ICD-10 Finland
Acute respiratory failure
6.4
8.8
22
35
K30
ICD-10 Finland
Functional dyspepsia
2.0
8.8
106
543
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
9.6
8.8
17
18
P29
ICPC
Psychological sympt/compl other
2.6
8.8
60
234
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.3
8.7
31
74
A04
ICPC
Weakness/tiredness general
2.0
8.7
114
605
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
8.7
290
2037
5780A
ICD-9 Finland
Gastro-intestinal haemorrhage, Haematemesis
50.4
8.7
10
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
6.7
8.7
21
32
X58
ICD-10 Finland
Exposure to other specified factors
1.8
8.7
165
995
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
8.7
753
6469
Z72.0
ICD-10 Finland
Tobacco use
3.2
8.7
44
142
F40.1
ICD-10 Finland
Social phobias
4.4
8.6
30
70
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.3
8.6
41
126
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
8.6
68
285
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
8.3
8.6
18
22
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
10.1
8.5
16
16
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
8.5
229
1528
A28
ICPC
Limited function/disability NOS
1.9
8.4
130
730
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
12.9
8.4
14
11
E14.1
ICD-10 Finland
Unspecified diabetes mellitus, with ketoacidosis
12.9
8.4
14
11
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.6
8.3
58
230
EBA30
NOMESCO Finland
Excision of root of tooth
2.3
8.3
73
327
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
2.8
8.3
50
182
E14
ICD-10 Finland
Unspecified diabetes mellitus
14.6
8.2
13
9
F05.9
ICD-10 Finland
Delirium, unspecified
4.1
8.2
30
74
F61.0
ICD-10 Finland
Mixed personality disorders
4.1
8.2
30
74
R95
ICPC
Chron obstructive pulmonary disease
3.1
8.2
42
137
A10AA02
ATC
NA
2.9
8.2
48
171
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
8.1
95
481
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.5
8.1
36
105
XPX00
NOMESCO Finland
Intraoperative angiography
17.3
8.1
12
7
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.8
8.1
32
85
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.6
8.1
56
221
Y09
ICD-10 Finland
Assault by unspecified means
9.0
8.0
16
18
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
4.2
8.0
29
71
K29.8
ICD-10 Finland
Duodenitis
5.9
8.0
21
36
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.2
8.0
81
387
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.1
8.0
41
134
GBB00
NOMESCO Finland
Tracheostomy
4.8
8.0
25
53
L02
ICPC
Back symptom/complaint
2.1
8.0
87
428
D06
ICPC
Abdominal pain localized other
2.3
7.9
72
325
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
5.2
7.9
23
45
-1
NOMESCO Finland
NA
1.5
7.8
328
2419
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.5
7.8
34
98
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
7.8
77
364
M10.9
ICD-10 Finland
Gout, unspecified
2.1
7.8
88
440
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
7.8
1000
9205
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
4.3
7.7
27
64
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
4.3
7.7
27
64
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.7
410
3176
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
45.3
7.7
9
*
JLB42
NOMESCO Finland
Transduodenal endoscopic dilatation of pancreatic duct
45.3
7.7
9
*
J01FF01
ATC
clindamycin; systemic
1.5
7.7
291
2098
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.9
7.7
45
160
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
2.4
7.7
62
264
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
7.6
75
351
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.0
7.6
41
139
S10
ICPC
Boil/carbuncle
2.3
7.6
65
286
ZXE90
NOMESCO Finland
More than 22 hours
8.1
7.6
16
20
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
11.9
7.6
13
11
L76
ICPC
Fracture: other
3.4
7.6
35
106
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
7.6
177
1133
T51.0
ICD-10 Finland
Toxic effect: Ethanol
8.9
7.6
15
17
S00.0
ICD-10 Finland
Superficial injury of scalp
4.2
7.5
27
66
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.5
7.4
33
97
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
5.1
7.4
22
44
JLD00
NOMESCO Finland
Pancreaticojejunostomy
80.6
7.4
8
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.2
7.4
37
119
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.6
7.4
31
87
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
13.5
7.4
12
9
N06AX12
ATC
bupropion; oral
2.3
7.4
66
296
L03
ICPC
Low back symptom/complaint
1.6
7.4
219
1493
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
7.4
282
2037
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
4.4
7.4
25
58
WZA90
NOMESCO Finland
Other doctors statement
1.6
7.3
231
1594
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
7.3
116
659
6101
FHL
Exploratory laparotomy, includes possible biopases
10.9
7.3
13
12
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
7.3
578
4807
K86
ICD-10 Finland
Other diseases of pancreas
+∞
7.3
7
*
6727
FHL
Cystoenterostomy (includes pseudocyst)
+∞
7.3
7
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
+∞
7.3
7
*
6701
FHL
Exploration and possible biopsy
+∞
7.3
7
*
E13.0
ICD-10 Finland
Other specified diabetes mellitus, with coma
+∞
7.3
7
*
A46
ICD-10 Finland
Erysipelas
1.7
7.3
159
999
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
7.3
57
240
EB1AA
SPAT
NA
2.6
7.2
51
204
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.3
7.2
66
302
R74
ICPC
Upper respiratory infection acute
1.6
7.2
228
1577
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.9
7.2
28
74
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
3.9
7.2
28
74
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.2
725
6285
R05
ICPC
Cough
1.6
7.2
191
1265
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
7.1
43
157
N06AG02
ATC
moclobemide; oral
2.5
7.1
53
217
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
7.1
156
980
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
6.6
7.1
17
26
K83.0
ICD-10 Finland
Cholangitis
5.1
7.1
21
42
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.6
7.1
205
1386
N05AD01
ATC
haloperidol; systemic
2.8
7.1
42
151
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.6
7.1
23
51
ZXA05
NOMESCO Finland
Left side
1.5
7.1
235
1643
E83.51
ICD-10 Finland
Hypocalcemia
8.8
7.1
14
16
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
4.4
7.0
24
56
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
10.1
7.0
13
13
WX110
SPAT
NA
2.5
7.0
52
211
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.7
7.0
22
47
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.8
7.0
42
153
D11
ICPC
Diarrhoea
1.9
7.0
99
542
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
7.0
71
339
ZY010
NOMESCO Finland
Hospital outpatient
2.5
7.0
53
221
SPAT1307
SPAT
Psychosocial counselling and guidance
2.5
7.0
53
221
A29
ICPC
General symptom/complaint other
1.9
7.0
102
563
Z02.7
ICD-10 Finland
Issue of medical certificate
2.2
7.0
66
306
K80
ICD-10 Finland
Cholelithiasis
6.4
6.9
17
27
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.9
6.9
102
565
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.1
6.9
35
114
N05CD08
ATC
midazolam; nasal, systemic
3.5
6.9
30
87
RS121
NOMESCO Finland
NA
7.6
6.9
15
20
C10AB05
ATC
fenofibrate; oral
3.3
6.9
32
98
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
13.9
6.9
11
8
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
13.9
6.9
11
8
EBA00
SPAT
NA
3.7
6.9
28
77
K20
ICD-10 Finland
Oesophagitis
3.8
6.9
27
72
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
6.9
84
436
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
3.1
6.9
35
115
K72.9
ICD-10 Finland
Hepatic failure, unspecified
8.3
6.8
14
17
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
6.8
72
349
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
6.8
159
1019
K08.3
ICD-10 Finland
Retained dental root
1.9
6.7
89
475
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.0
6.7
37
128
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.7
6.7
21
45
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
4.1
6.7
24
59
A97
ICPC
No disease
1.7
6.7
130
790
L28
ICPC
Limited function/disability (L)
1.7
6.7
126
755
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.9
6.7
96
527
R03BB04
ATC
tiotropium bromide; inhalant
1.8
6.7
107
612
J01MA14
ATC
moxifloxacin; systemic
1.9
6.6
92
499
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.2
6.6
66
311
DQA10
NOMESCO Finland
Biopsy of larynx
6.5
6.6
16
25
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
5.2
6.6
19
37
9128
FHL
Open reduction and osteosynthesis
2.8
6.6
40
147
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
4.6
6.6
21
46
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
12.3
6.6
11
9
C09AA05
ATC
ramipril; oral
1.5
6.5
258
1872
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
6.5
43
166
R18
ICD-10 Finland
Ascites
3.5
6.5
28
81
L05
ICPC
Flank/axilla symptom/complaint
2.3
6.5
58
262
B86
ICD-10 Finland
Scabies
5.1
6.5
19
38
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.7
6.5
26
71
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.5
509
4198
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
5.4
6.5
18
34
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
6.5
119
710
S72.1
ICD-10 Finland
Pertrochanteric fracture
4.3
6.4
22
52
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
2.8
6.4
39
144
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
6.4
45
178
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
4.7
6.4
20
43
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.5
6.4
46
188
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
6.3
82
435
I81
ICD-10 Finland
Portal vein thrombosis
8.2
6.3
13
16
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
6.3
73
368
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.0
6.3
33
111
N05AA03
ATC
promazine; systemic
18.1
6.3
9
5
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
18.1
6.3
9
5
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
6.3
51
221
C09AA02
ATC
enalapril; systemic
1.5
6.3
197
1356
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.9
6.3
36
127
6728
FHL
Drainage of abscess or pancreatitis (includes lavage)
+∞
6.3
6
*
WX290
SPAT
NA
3.2
6.3
30
95
K81.9
ICD-10 Finland
Cholecystitis, unspecified
4.3
6.2
21
49
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
6.2
105
608
Y07
ICD-10 Finland
Other maltreatment
4.8
6.2
19
40
29120
ICD-8 Finland
Alcoholic psychosis, Other alcoholic hallucinosis
26.8
6.2
8
*
5604
FHL
Vascular preparation or cannulation in the operating room
26.8
6.2
8
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
7.1
6.2
14
20
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.0
6.2
32
107
R55
ICD-10 Finland
Syncope and collapse
1.8
6.2
103
597
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
6.3
6.2
15
24
S01.7
ICD-10 Finland
Multiple open wounds of head
5.4
6.2
17
32
QAB00
NOMESCO Finland
Suture of skin of head or neck
3.4
6.1
27
80
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.6
6.1
42
167
5CM18
NOMESCO Finland
NA
7.7
6.1
13
17
M54
ICD-10 Finland
Dorsalgia
1.8
6.1
104
605
A02BA04
ATC
nizatidine; systemic
1.9
6.1
82
441
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.1
357
2792
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.1
102
591
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
12.6
6.1
10
8
C10AA01
ATC
simvastatin; oral
1.4
6.1
434
3513
L08
ICPC
Shoulder symptom/complaint
1.6
6.1
181
1234
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.4
6.1
49
210
205
Kela drug reimbursment
Chronic hypertension
1.5
6.0
265
1963
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.5
6.0
46
191
J37.0
ICD-10 Finland
Chronic laryngitis
2.7
6.0
37
138
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
10.1
6.0
11
11
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
10.1
6.0
11
11
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.0
112
671
K07
ICPC
Swollen ankles/oedema
2.6
6.0
41
163
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000570) Elastase.pancreatic [Mass/mass] in Stool
264
308
10.48
215.55
1.8
1.4
ug/g
163.2
271.2
9.96
160
181
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
472
1259
5.29
171.75
5.5
3.0
umol/l
10.0
9.0
0.37
416
1130
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
416
998
5.64
171.17
9.1
2.5
u/l
86.4
87.6
0.01
371
878
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
794
3337
4.49
157.19
7.5
2.7
u/l
100.8
57.7
9.96
750
3123
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
982
5533
4.08
112.83
14.0
6.7
umol/l
13.3
12.2
0.98
943
5281
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
473
1710
3.76
107.95
3.3
2.0
%
1.9
1.5
9.76
404
1511
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
348
1058
4.12
101.35
3.7
2.3
g/l
0.2
0.2
6.94
328
982
(3023368) Bacteria identified in Blood by Culture
650
3042
3.25
95.62
6.9
4.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
609
2762
3.25
94.20
9.4
4.2
%
86.6
88.6
1.27
592
2709
(3023183) Ammonium ion [Moles/volume] in Plasma
171
306
6.28
93.49
4.2
3.0
umol/l
38.3
37.3
0.10
151
262
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
703
3581
3.07
86.87
5.7
3.5
u/l
58.6
40.2
0.68
665
3389
(3024561) Albumin [Mass/volume] in Serum or Plasma
801
4468
3.04
82.57
9.3
5.3
g/l
32.7
35.7
27.53
755
4194
(3003458) Phosphate [Moles/volume] in Serum or Plasma
371
1422
3.24
73.41
7.6
7.1
mmol/l
1.0
1.0
0.40
351
1334
(3014111) Lactate [Moles/volume] in Serum or Plasma
297
1001
3.54
72.23
11.7
8.7
mmol/l
1.6
1.4
1.69
287
970
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
782
4546
2.78
70.37
11.3
6.8
mmol/l
1.2
1.2
9.81
736
4136
(3012095) Magnesium [Moles/volume] in Serum or Plasma
422
1782
3.02
70.15
4.7
3.8
mmol/l
0.8
0.8
20.47
400
1687
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
193
512
4.25
65.95
5.6
4.3
mmol/l
23.6
24.2
1.14
176
465
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
131
258
5.53
64.16
1.3
1.8
nmol/l
0.6
0.9
3.14
105
228
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
814
4986
2.67
63.38
11.8
7.4
mmol/l
1.2
1.2
7.86
702
4237
(3013826) Glucose [Moles/volume] in Serum or Plasma
954
6336
2.85
62.90
10.6
5.3
mmol/l
7.7
6.8
17.42
921
5993
(3000991) Gas panel - Venous blood
273
946
3.38
62.87
14.1
10.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
557
2904
2.60
59.73
5.5
4.5
ph
7.4
7.4
0.12
98
569
(3020779) Urea [Moles/volume] in Serum or Plasma
287
1062
3.18
59.00
8.2
8.8
mmol/l
9.0
9.7
0.93
273
1018
(3032080) INR in Blood by Coagulation assay
742
4464
2.52
58.11
9.9
9.2
inr
1.2
1.3
2.96
192
1263
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
84
122
7.29
55.59
1.4
1.2
nmol/l
0.8
1.5
6.38
76
110
(3044640) Blood type and Crossmatch panel - Blood
586
3232
2.47
54.48
4.2
2.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
101
182
5.93
54.24
1.4
1.7
g/l
0.7
0.9
0.61
53
140
(3020191) Ethanol [Moles/volume] in Serum or Plasma
74
100
7.78
52.14
2.3
1.5
promille
2.2
1.2
3.87
54
81
(3012544) pH of Venous blood
270
1031
3.04
52.05
5.7
4.0
—
7.4
—
0
8
(3009508) Creatinine [Moles/volume] in Urine
616
3550
2.39
50.99
4.2
3.3
mmol/l
7.1
8.6
12.06
513
2999
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
482
2506
2.46
50.12
3.8
2.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
261
1002
3.00
49.66
5.7
3.9
mmol/l
1.2
2.0
1.85
219
788
(3002582) Erythrocytes [#/volume] in Urine
571
3222
2.37
49.13
3.9
3.3
e6/l
33.9
93.9
1.76
454
2498
(3021447) Carbon dioxide [Partial pressure] in Venous blood
259
1002
2.97
48.52
5.8
3.9
kpa
5.7
5.9
1.42
251
970
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
187
600
3.47
47.93
15.0
12.4
mmol/l
23.4
24.4
2.82
179
574
(3030467) Casts [#/volume] in Urine by Automated count
532
2942
2.36
47.60
3.9
3.2
e6/l
0.6
0.5
0.57
419
2223
(36304419) Bacteria [Presence] in Urine
521
2873
2.35
46.73
3.9
3.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
457
2392
2.40
46.08
2.5
2.1
mg/l
2.8
3.0
0.51
387
2046
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1075
8138
2.78
45.53
16.0
7.9
u/l
91.4
78.1
14.80
1037
7714
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
51
51
10.36
45.35
2.7
1.9
umol/l
119.3
125.1
0.05
29
29
(3000850) Epithelial cells [#/volume] in Urine
427
2189
2.41
44.93
3.0
2.6
e6/l
5.5
3.9
1.38
380
1926
(3026782) Osmolality of Urine
405
2029
2.44
44.84
3.1
2.8
mosm/kgh2o
487.3
582.1
13.91
350
1731
(3018095) Leukocytes [#/volume] in Urine
608
3639
2.25
44.22
4.4
3.7
e6/l
53.4
94.3
0.66
469
2667
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
633
3862
2.23
43.79
4.0
3.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
564
3351
2.20
40.92
4.0
3.3
mg/l
408.5
251.6
0.38
379
2300
(3028707) Methadone [Presence] in Urine by Screen method
83
167
5.24
39.43
4.1
3.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
885
6345
2.21
38.82
5.1
3.9
e6/l
1154.7
921.4
—
7
92
(3020682) Albumin/Creatinine [Ratio] in Urine
577
3523
2.14
38.39
5.0
4.1
mg/mmol
20.2
8.9
2.74
380
2383
(40758558) Short blood count panel - Blood
459
2570
2.21
38.04
7.1
7.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
292
1347
2.50
37.94
14.5
8.6
kpa
4.9
5.2
2.80
279
1297
(3003396) Base excess in Arterial blood by calculation
291
1341
2.50
37.89
14.6
8.6
mmol/l
0.0
1.1
2.50
242
1061
(3027801) Oxygen [Partial pressure] in Arterial blood
292
1348
2.50
37.87
14.5
8.6
kpa
11.1
12.1
4.12
279
1301
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
394
2079
2.28
37.70
5.1
3.7
ng/l
76.9
525.3
7.19
322
1647
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
633
4034
2.10
37.29
2.4
1.9
pmol/l
87.2
94.0
3.38
362
2257
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
50
66
7.84
35.85
1.3
1.3
mmol/l
12.2
12.6
0.12
45
26
(3015377) Calcium [Moles/volume] in Serum or Plasma
533
3228
2.10
35.52
3.7
3.4
mmol/l
2.3
2.3
4.84
471
2860
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
338
1709
2.32
35.49
3.1
3.0
e6/l
1.7
0.9
0.97
179
953
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
336
1701
2.31
35.13
2.0
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
325
1623
2.33
35.08
3.1
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
350
1826
2.25
33.90
3.1
2.8
e6/l
0.7
0.9
1.16
193
1065
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
132
422
3.37
33.66
2.6
2.5
ug/l
387.5
494.1
0.33
126
400
(3016502) Oxygen saturation in Arterial blood
266
1242
2.43
33.27
15.6
8.8
%
95.2
95.7
0.71
258
1199
(3024354) Oxygen [Partial pressure] in Venous blood
202
827
2.71
33.23
4.2
3.0
kpa
4.9
4.6
0.80
193
799
(3011288) Drugs identified in Urine by Screen method
92
232
4.19
33.12
4.2
3.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
80
184
4.57
32.41
1.1
1.1
iu/ml
5.0
34.3
1.16
12
44
(3051651) Icteric interference index of Serum or Plasma
48
68
7.29
32.36
4.9
3.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
701
4810
1.98
31.87
5.8
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
826
6041
1.99
30.73
8.8
9.5
e9/l
5.2
4.2
16.10
731
5282
(3019309) Folate [Moles/volume] in Red Blood Cells
330
1750
2.18
30.26
2.0
1.7
nmol/l
1143.8
1164.8
0.14
252
1361
(3003181) Sodium [Moles/volume] in Urine
70
154
4.75
29.93
1.5
1.3
mmol/l
57.6
62.4
0.29
50
130
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
229
1046
2.44
29.82
3.2
4.6
ug/l
5.4
27.0
1.85
196
872
(3002173) Hemoglobin [Mass/volume] in Arterial blood
245
1154
2.38
29.79
16.4
9.3
g/l
117.5
124.9
5.25
239
1108
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
126
422
3.20
29.71
2.9
3.9
u/ml
155.4
3417.2
0.77
111
363
(44816559) Phosphatidylethanol [Mass/volume] in Blood
90
243
3.90
29.49
2.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
53
94
5.83
28.81
5.0
3.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
548
3574
1.92
27.78
5.1
6.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
88
247
3.75
27.27
3.2
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
95
284
3.53
26.81
3.7
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
173
727
2.59
26.74
1.6
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
270
1382
2.20
26.71
1.4
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
42
64
6.75
26.49
1.4
1.5
nmol/l
0.8
1.2
1.49
27
51
(3027135) IgG subclass 1 [Mass/volume] in Serum
54
106
5.27
26.33
1.3
1.3
g/l
6.0
6.8
0.87
18
70
(3028192) IgG subclass 2 [Mass/volume] in Serum
54
106
5.27
26.33
1.3
1.3
g/l
3.4
3.0
0.45
18
71
(3024139) IgG subclass 3 [Mass/volume] in Serum
54
106
5.27
26.33
1.3
1.3
g/l
0.4
0.4
0.54
17
70
(4062490)
54
107
5.22
26.06
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
967
7673
1.99
25.97
8.4
3.2
u/l
123.2
57.0
15.09
911
7234
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
501
3233
1.89
25.75
3.0
2.2
u/l
285.6
286.6
0.01
474
3057
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
155
630
2.66
25.59
1.8
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
249
1262
2.20
25.11
2.0
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
112
386
3.08
25.09
2.9
2.7
u/ml
0.3
0.3
0.64
58
215
(3017143) Hepatitis C virus Ab [Presence] in Serum
245
1237
2.21
24.93
1.8
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
238
1188
2.23
24.91
1.9
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
380
2258
1.96
24.90
1.8
1.5
nmol/l
21.2
19.9
0.88
339
1947
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
160
673
2.57
24.61
17.2
11.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
95
300
3.34
24.60
6.4
3.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
271
1432
2.12
24.53
3.1
2.7
%
25.8
24.2
0.68
233
1237
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
239
1204
2.20
24.42
1.9
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
97
313
3.27
24.25
1.2
1.2
titre
87.7
94.0
0.08
13
30
(3027945) Reticulocytes/100 erythrocytes in Blood
236
1186
2.21
24.24
2.0
2.6
%
1.9
1.8
1.14
201
1065
(3004789) Transferrin [Mass/volume] in Serum or Plasma
280
1511
2.08
23.92
3.1
2.6
g/l
2.1
2.3
4.46
255
1413
(3016879) Cocaine [Presence] in Urine
102
346
3.11
23.46
3.7
2.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
675
4901
1.78
22.67
5.4
6.4
%
2.7
2.9
1.83
631
4604
(3022948) Iron [Moles/volume] in Serum or Plasma
291
1622
2.02
22.62
3.0
2.6
umol/l
11.9
13.8
4.05
267
1522
(3019069) Monocytes/100 leukocytes in Blood
677
4926
1.77
22.51
5.6
6.7
%
8.9
9.0
0.25
638
4641
(3022096) Basophils/100 leukocytes in Blood
659
4779
1.76
21.98
5.4
6.4
%
0.6
0.7
0.78
620
4497
(3005719) IgG [Mass/volume] in Serum or Plasma
180
848
2.30
21.46
2.1
2.4
g/l
10.9
10.6
0.29
146
785
(3000764) Benzodiazepines [Presence] in Urine
102
368
2.92
21.04
3.7
2.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
674
4962
1.74
20.94
5.4
6.3
%
60.0
57.3
7.52
634
4681
(3002030) Lymphocytes/100 leukocytes in Blood
681
5035
1.73
20.78
5.6
6.5
%
24.3
27.5
12.28
636
4726
(3033799) Differential panel - Peritoneal fluid
27
33
8.33
20.56
1.3
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
102
375
2.86
20.33
3.8
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
561
3948
1.74
20.30
3.4
2.7
ug/l
213.4
175.7
1.44
501
3658
(3022217) INR in Platelet poor plasma by Coagulation assay
250
1368
2.02
20.26
15.7
23.0
inr
1.1
1.3
2.65
40
186
(3018677) aPTT in Platelet poor plasma by Coagulation assay
298
1735
1.93
20.18
2.3
2.2
s
30.5
29.9
0.93
291
1686
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
242
1312
2.04
20.11
1.7
1.6
—
—
—
0
0
(4198724)
33
54
6.24
19.44
2.3
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
296
1739
1.91
19.42
3.5
3.2
mmol/l
2.5
2.4
1.56
250
1535
(3027008) Opiates [Presence] in Urine
100
374
2.81
19.30
3.8
2.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
98
369
2.79
18.68
3.9
2.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
77
257
3.12
18.19
4.0
4.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
118
495
2.52
18.13
1.7
1.8
g/l
1.7
1.6
1.03
101
423
(3026008) Bacteria identified in Urine by Culture
359
2292
1.78
17.81
3.1
2.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
689
5260
1.65
17.43
5.4
6.1
e9/l
0.0
0.0
1.71
590
4557
(3037467) Urinalysis macro (dipstick) panel - Urine
859
6942
1.69
17.39
4.9
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
137
628
2.32
17.30
1.6
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
529
3783
1.67
17.23
2.6
2.2
nmol/l
66.2
74.3
7.43
467
3415
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
222
1231
1.97
17.11
2.8
4.4
u/l
213.2
240.0
4.89
204
1174
(3019198) Lymphocytes [#/volume] in Blood
698
5374
1.64
16.85
5.5
6.2
e9/l
1.8
2.0
1.67
600
4748
(3023520) Reticulocytes [#/volume] in Blood
174
890
2.10
16.75
2.3
2.7
e9/l
69.6
71.1
0.20
118
689
(3013115) Eosinophils [#/volume] in Blood
703
5429
1.64
16.71
5.9
6.4
e9/l
0.2
0.2
0.51
605
4786
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
139
652
2.27
16.62
5.5
4.5
ng/l
106.9
93.7
0.89
123
582
(3001604) Monocytes [#/volume] in Blood
683
5242
1.63
16.60
5.4
6.1
e9/l
0.7
0.6
8.74
584
4535
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
566
4149
1.64
16.53
5.2
3.6
ng/l
49.2
52.5
0.05
434
2945
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
39
89
4.49
15.97
1.5
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
70
246
2.95
15.14
6.0
5.5
mmol/l
2.4
2.4
0.03
52
167
(3010421) pH of Blood
79
299
2.75
14.91
5.7
5.1
ph
7.4
7.4
0.08
63
243
(1761868) Lipid panel - Serum or Plasma
292
4292
0.59
13.96
3.1
2.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
31
66
4.79
13.81
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
31
66
4.79
13.81
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
288
1841
1.72
13.77
1.6
1.4
g/l
3.7
2.6
5.84
160
1200
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
65
235
2.86
13.38
2.3
3.9
u/ml
40.4
267.0
1.32
56
221
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
302
1971
1.69
13.33
1.3
1.2
u/ml
2.7
1.7
0.49
63
561
(3004588) Protein electrophoresis panel - Serum or Plasma
134
678
2.09
13.19
2.2
2.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
69
4.58
13.11
1.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
142
740
2.03
12.91
3.9
3.4
ph
7.4
7.4
0.03
20
97
(3011397) Hemoglobin [Presence] in Urine by Test strip
335
2264
1.64
12.87
3.5
3.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
193
1118
1.85
12.82
6.2
3.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
143
750
2.02
12.77
3.9
3.4
kpa
5.0
5.2
1.18
133
696
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
56
192
3.00
12.68
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
60
214
2.89
12.67
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
60
214
2.89
12.67
1.3
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
13
11
11.93
12.65
5.9
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
137
710
2.04
12.64
3.8
3.4
mmol/l
1.2
1.7
0.56
98
529
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
80
340
2.44
11.96
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
406
2920
1.57
11.88
1.8
1.7
mmol/l
2.0
1.5
2.52
354
2457
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
26
55
4.80
11.68
1.4
1.6
iu/ml
—
1679021.4
—
0
7
(46235355) HIV 1 and 2 tests - Meaningful Use set
257
1660
1.68
11.64
2.1
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
143
777
1.94
11.52
10.2
4.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
153
856
1.89
11.29
2.2
2.7
g/l
66.4
66.4
0.01
133
795
(3023487) Leukocytes [#/volume] in Peritoneal fluid
23
45
5.18
11.28
1.4
2.4
e6/l
1315.4
1051.7
0.12
13
36
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
80
350
2.37
11.23
3.2
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
173
1017
1.81
10.89
2.7
2.4
ug/l
4.8
8.7
3.69
154
932
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
76
331
2.38
10.78
2.3
2.8
g/l
0.4
1.3
2.05
63
302
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
359
2.31
10.61
2.1
2.6
g/l
3.1
3.1
0.09
63
292
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
70
298
2.43
10.45
2.7
2.8
g/l
0.1
0.0
0.19
61
280
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
326
2287
1.57
10.43
1.8
1.8
mg/l
1.4
1.2
0.37
251
1775
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
15
8.74
10.24
2.1
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
79
362
2.26
9.98
2.4
2.3
%
77.1
90.1
3.44
73
347
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
74
334
2.29
9.70
3.4
3.0
mg/l
1.9
1.5
2.31
64
312
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
81
381
2.20
9.62
2.2
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
356
2.24
9.54
2.2
2.6
g/l
10.4
10.3
0.07
62
311
(3016650) Hepatitis A virus Ab [Presence] in Serum
51
195
2.68
9.51
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
122
670
1.91
9.51
1.8
1.7
g/l
1.1
1.4
1.58
111
626
(3026493) Urate [Moles/volume] in Serum or Plasma
413
3099
1.49
9.50
2.8
2.7
umol/l
378.2
5396.8
8.31
359
2736
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
65
280
2.39
9.47
2.4
2.8
g/l
0.0
0.0
0.00
56
262
(3028271) Lactate [Moles/volume] in Capillary blood
48
179
2.75
9.39
2.4
2.2
mmol/l
1.8
1.6
0.38
48
172
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
19
37
5.20
9.37
1.4
2.0
e6/l
2449.5
2984.9
—
8
23
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
381
2.17
9.22
2.1
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
381
2.17
9.22
2.1
2.5
g/l
4.1
3.9
0.70
61
287
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
381
2.17
9.22
2.2
2.5
g/l
7.5
7.2
0.57
63
299
(3036489) Thrombin time
85
415
2.12
9.20
1.8
2.2
s
23.5
22.3
0.48
75
373
(36660697) Celiac disease serology panel - Serum
123
685
1.88
9.19
1.2
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
64
278
2.37
9.16
2.4
2.8
g/l
0.0
0.0
0.00
56
262
(3021589) Normoblasts [#/volume] in Blood
583
4696
1.43
9.16
14.2
9.7
e9/l
0.0
0.0
0.07
482
3864
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
69
310
2.29
9.15
2.3
2.7
g/l
36.6
37.8
0.65
58
273
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
47
4.52
8.85
3.3
2.8
—
—
—
0
0
(3020891) Body temperature
92
474
2.01
8.63
8.0
4.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
100
538
1.93
8.30
4.0
3.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
91
474
1.99
8.29
2.3
2.1
ug/l
4.6
2.2
0.71
84
430
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
61
272
2.30
8.26
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
17
34
5.05
8.15
1.6
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
82
414
2.05
8.14
2.4
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
56
243
2.36
8.07
3.2
2.7
%
15.1
16.8
1.70
24
131
(3036481) Cortisol [Moles/volume] in Serum or Plasma
150
930
1.69
7.79
2.2
2.3
nmol/l
337.4
364.6
1.07
135
874
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
89
473
1.95
7.67
4.2
3.7
mmol/l
24.7
24.8
0.14
84
449
(3013707) Erythrocyte sedimentation rate by Westergren method
867
7640
1.40
7.38
4.2
3.9
mm/h
16.6
11.0
14.78
795
7101
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
51
224
2.33
7.18
1.4
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
68
1272
0.51
6.98
1.3
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
197
1341
1.55
6.98
1.2
1.3
titre
272.0
410.7
1.41
35
259
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
39
4.40
6.97
1.5
2.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
67
336
2.05
6.81
3.3
3.6
mg/l
38.1
52.0
0.39
52
267
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
50
223
2.29
6.81
1.4
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
130
806
1.68
6.75
1.6
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
66
336
2.02
6.46
3.3
3.6
mg/l
55.2
78.6
0.56
50
264
(3047181) Lactate [Moles/volume] in Blood
71
373
1.96
6.36
13.2
6.2
mmol/l
1.7
1.3
1.65
57
323
(3000494) Fungus identified in Specimen by Culture
190
1314
1.52
6.24
1.8
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
47
213
2.25
6.19
1.4
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
32
121
2.69
6.18
1.1
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
43
189
2.32
6.08
1.1
1.1
g/l
1.7
1.5
1.67
38
172
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
279
2096
1.42
5.99
2.0
1.6
pmol/l
432.9
37647472.9
2.15
218
1785
(3026692) Albumin [Mass/volume] in Peritoneal fluid
14
31
4.55
5.99
1.1
1.4
g/l
8.1
12.2
—
9
20
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
1150
0.53
5.98
2.0
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
29
106
2.78
5.98
1.2
1.2
mosm/kgh2o
277.4
284.6
0.82
21
83
(3035350) Ketones [Presence] in Urine by Test strip
586
4959
1.33
5.90
3.8
3.2
estimate
0.0
0.0
0.00
119
939
(3006653) Thiamine [Moles/volume] in Blood
22
69
3.23
5.88
1.0
1.2
nmol/l
148.4
145.3
0.09
22
69
(3015235) Bicarbonate [Moles/volume] in Capillary blood
58
293
2.02
5.82
3.3
2.8
mmol/l
23.4
24.9
1.61
48
256
(3002331) Protein [Mass/volume] in Peritoneal fluid
12
24
5.04
5.75
1.1
1.5
g/l
6.6
26.7
—
7
15
(40760888) Immunoglobulin light chains.free panel - Serum
50
243
2.10
5.57
3.3
3.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
8
11.32
5.29
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
38
170
2.27
5.20
6.0
6.8
mg/l
11.7
10.9
0.60
33
157
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
103
2.66
5.17
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
60
321
1.91
5.15
1.6
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
129
858
1.56
5.06
4.9
3.7
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
11
23
4.81
5.02
1.7
2.1
mmol/l
1.1
1.2
0.50
11
23
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
120
788
1.58
4.98
6.2
4.4
mmol/l
1.2
1.2
2.82
105
697
(3009261) Glucose [Presence] in Urine by Test strip
581
4994
1.29
4.93
3.8
3.2
estimate
0.0
0.0
0.50
116
898
(3021601) Nitrite [Presence] in Urine by Test strip
574
4936
1.29
4.82
5.0
4.3
estimate
0.0
0.0
0.50
129
967
(3019225) pH of Specimen
140
960
1.51
4.79
5.0
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1131
10677
1.43
4.73
34.8
14.2
mg/l
43.1
25.8
28.11
1043
8450
(3008152) Bicarbonate [Moles/volume] in Arterial blood
115
761
1.56
4.63
16.0
7.1
mmol/l
24.5
24.6
0.03
109
708
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
37
174
2.16
4.53
3.1
3.0
u/ml
1041.7
144.0
0.40
37
165
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
39
747
0.51
4.34
1.5
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
128
881
1.50
4.31
2.9
2.6
ml/min/173m2
73.8
68.9
0.42
51
325
(3010813) Leukocytes [#/volume] in Blood
1163
12060
0.69
4.26
45.7
20.5
e9/l
7.8
6.7
40.93
1136
11744
(3024891) Influenza virus A+B Ag [Presence] in Specimen
52
284
1.87
4.24
1.2
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1163
12058
0.69
4.22
46.2
20.6
g/l
130.7
140.5
66.66
1149
11898
(3026361) Erythrocytes [#/volume] in Blood
1163
12057
0.69
4.20
45.7
20.5
e12/l
4.3
4.6
75.57
1134
11741
(3017509) Phencyclidine [Presence] in Urine
9
13
6.96
4.16
1.9
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
1163
12055
0.69
4.16
45.6
20.4
fl
92.2
91.0
13.64
1151
11900
(3035941) MCH [Entitic mass]
1163
12055
0.69
4.16
45.5
20.4
pg
30.9
30.5
7.54
1151
11899
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
23
4.37
4.09
3.1
2.5
—
—
—
0
0
(4281824)
18
63
2.88
4.07
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1163
12049
0.69
4.04
45.8
20.5
e9/l
248.3
240.4
2.98
1142
11761
(3019832) Treponema pallidum Ab [Presence] in Serum
91
590
1.58
4.02
1.8
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
803
7293
1.26
3.98
3.5
3.3
pmol/l
14.5
14.8
1.80
710
6637
(3019550) Sodium [Moles/volume] in Serum or Plasma
1163
11098
1.42
3.98
39.9
16.4
mmol/l
138.1
139.7
60.24
1145
10853
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
451
5216
0.79
3.80
3.9
3.9
%
20.9
21.4
0.25
177
2365
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
96
2.42
3.74
1.0
1.2
u/l
63.6
57.6
0.19
14
71
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
122
2.24
3.68
3.5
4.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
79
2.56
3.64
1.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
199
1.94
3.56
1.2
2.0
—
—
—
0
0
(3019977) pH of Arterial blood
17
63
2.72
3.49
4.5
3.6
ph
7.4
7.4
—
7
22
(4146454)
26
120
2.19
3.39
3.1
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
43
239
1.83
3.38
2.6
2.3
g/l
125.0
133.6
1.37
33
173
(4010399)
108
757
1.46
3.37
1.4
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
53
2.85
3.36
1.8
1.8
—
—
—
0
0
(3013512) EKG study
366
3085
1.26
3.36
4.7
3.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1162
11144
1.37
3.32
40.0
16.6
mmol/l
4.0
4.0
8.20
1144
10891
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
74
480
1.57
3.31
2.0
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
23
102
2.28
3.30
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
66
417
1.61
3.29
2.1
2.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
44
249
1.79
3.27
1.2
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
39
214
1.85
3.20
3.5
2.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
44
2.97
3.14
1.0
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
118
2.14
3.11
1.4
1.4
e6/l
11659.8
67335.8
—
10
70
(3023199) Leukocytes [#/volume] in Pleural fluid
27
132
2.07
3.08
1.4
1.5
e6/l
1842.7
1649.5
0.14
15
91
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43
249
1.75
2.99
4.4
6.8
iu/ml
661.0
602.9
—
6
41
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
46
272
1.72
2.97
1.2
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
39
220
1.80
2.96
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
111
803
1.42
2.95
1.8
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
35
3.16
2.93
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
47
281
1.70
2.92
1.2
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
128
2.05
2.92
1.2
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
89
2.27
2.87
1.1
1.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
13
5.41
2.87
1.6
2.3
ng/l
98.3
112.8
—
7
13
(3039443) Prostate specific Ag panel - Serum or Plasma
27
504
0.53
2.85
1.3
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
45
268
1.70
2.85
1.4
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
116
2.09
2.84
1.3
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
979
9238
1.24
2.81
4.7
4.0
mu/l
1.9
2.1
0.70
885
8457
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
26
132
1.99
2.71
2.0
2.2
pg
32.0
33.4
0.56
26
132
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
331
3841
0.82
2.64
2.9
2.8
ug/l
0.6
0.7
2.83
220
2405
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
113
2.05
2.62
2.6
2.6
u/l
9.9
3305.3
—
5
30
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
48
299
1.63
2.59
2.0
2.5
ug/min
253.0
146.5
0.30
18
179
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
20
4.02
2.57
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
80
560
1.46
2.57
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
119
896
1.36
2.53
1.9
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
294
1.62
2.50
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
47
295
1.62
2.47
1.3
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
16
4.39
2.47
1.0
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
188
1.77
2.46
2.1
3.2
—
2907.6
—
0
15
(3021788) Differential panel - Synovial fluid
33
188
1.77
2.46
1.2
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
116
2.00
2.46
2.4
2.2
mg/l
10.2
20.3
—
6
30
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
21
3.83
2.46
1.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
21
3.83
2.46
2.0
2.1
mmol/l
1.2
1.2
—
8
21
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
345
2977
1.22
2.46
3.0
3.1
ng/l
2084.5
1306.5
1.48
293
2535
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
166
1.83
2.46
1.2
1.8
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
28
152
1.86
2.44
1.4
1.5
g/l
29.7
32.1
0.38
23
134
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
242
1.67
2.43
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
47
297
1.60
2.41
1.3
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
34
2.96
2.41
3.7
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
34
2.96
2.41
3.7
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1051
10925
0.81
2.38
4.9
4.5
mmol/l
4.3
4.6
11.01
968
10242
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1045
10867
0.81
2.36
4.9
4.4
mmol/l
1.3
1.3
6.93
951
10123
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
40
245
1.65
2.33
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
892
0.68
2.32
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
51
333
1.55
2.30
1.3
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
23
3.49
2.27
1.4
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
18
3.90
2.25
6.4
5.6
mmol/l
7.1
6.2
—
7
18
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
142
1.85
2.24
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
143
1.83
2.20
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
24
3.35
2.18
1.0
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
822
7708
1.18
2.17
4.4
3.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1069
10262
1.23
2.17
29.6
13.0
ml/min/173m2
87.4
82.9
7.28
929
8564
(3003694) ABO and Rh group [Type] in Blood
334
2906
1.20
2.16
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
22
115
1.93
2.16
1.1
2.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
61
2.31
2.15
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
55
2.38
2.12
1.1
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
205
1.68
2.12
1.1
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
102
1.98
2.11
1.3
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
11
43
2.57
2.10
1.6
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1059
10168
1.22
2.08
8.7
5.7
mmol/mol
46.3
40.2
21.63
993
9523
(3004716) Salmonella sp identified in Stool by Organism specific culture
64
452
1.44
2.01
1.4
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
110
854
1.31
1.95
2.9
2.8
ng/l
276.0
185.9
0.95
100
768
(3019150) Specific gravity of Urine by Refractometry
255
2184
1.21
1.95
4.0
3.4
kg/l
1.0
1.0
1.20
39
292
(3000492) Spirometry study
146
1177
1.27
1.94
1.5
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
45
299
1.52
1.92
1.9
2.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
106
1.90
1.91
2.8
2.6
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
50
0.00
1.89
0.0
1.1
—
1.7
—
0
18
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
229
1.59
1.86
1.4
1.2
u/ml
332.6
286.2
0.35
19
142
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
167
1.69
1.85
1.1
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
927
8836
1.17
1.80
38.5
17.2
%
14.0
13.6
14.49
914
8663
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
23
3.05
1.80
3.0
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
47
2.35
1.78
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
170
1.66
1.74
4.6
4.2
—
—
—
0
0
(3002256) Pathology report gross observation
156
1286
1.24
1.73
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
305
2683
1.18
1.72
4.8
3.5
estimate
0.0
0.0
0.15
107
910
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
38
250
1.54
1.72
1.5
1.4
—
16.9
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
5
13
3.86
1.71
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
111
1.81
1.69
1.0
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
22
126
1.76
1.68
3.3
7.0
mmol/l
7.6
7.2
0.23
17
105
(3002619) Bacteria identified in Specimen by Culture
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
41
277
1.50
1.65
20.4
6.7
mmol/l
103.1
105.5
1.64
36
246
(3039000) Anion gap in Blood
41
277
1.50
1.65
20.3
6.7
mmol/l
11.4
11.5
0.04
36
246
(3006442) Creatine [Moles/volume] in Serum or Plasma
17
90
1.90
1.65
1.9
1.7
—
76.3
—
0
9
(3007930) Methemoglobin/Hemoglobin.total in Blood
64
471
1.38
1.64
14.2
5.3
%
0.9
0.9
0.16
59
439
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
19
105
1.82
1.63
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
29
447
0.64
1.59
1.4
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
430
3909
1.15
1.57
2.1
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1079
11100
0.84
1.57
5.6
4.9
mmol/l
2.4
2.8
25.67
989
10344
(3020876) Protein [Mass/time] in 24 hour Urine
17
92
1.86
1.56
1.7
2.2
—
1.6
—
0
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
57
2.12
1.55
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
44
2.28
1.53
1.5
1.0
miu/ml
1535.5
1291.1
—
10
44
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
15
3.34
1.52
1.0
1.0
mg/g
11.4
9.7
—
5
15
(40765096) Chromosome analysis panel by Banding
0
43
0.00
1.52
0.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
125
0.40
1.50
7.2
2.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
72
551
1.32
1.47
1.9
2.9
e6/l
0.2
0.2
0.08
67
539
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
125
1.69
1.44
1.8
4.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
16
3.13
1.44
1.0
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
59
2.04
1.43
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
53
388
1.38
1.43
3.5
3.6
g/l
0.6
0.3
0.93
32
186
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
63
477
1.34
1.39
14.9
5.3
%
2.2
1.7
1.08
58
445
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
54
399
1.37
1.39
1.5
1.6
—
561.5
—
0
13
(3035880) pH of Pleural fluid
13
67
1.95
1.38
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
159
1.58
1.35
2.5
2.9
nmol/l
0.7
0.9
1.12
17
122
(3021387) Prolactin [Units/volume] in Serum or Plasma
42
299
1.42
1.34
1.2
1.6
mu/l
224.1
286.3
1.74
36
282
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
75
1.88
1.34
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
75
1.88
1.34
1.4
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
145
1222
1.21
1.34
1.4
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
38
0.00
1.34
0.0
3.6
—
95.0
—
0
38
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
38
0.00
1.34
0.0
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
258
0.58
1.32
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
178
1.53
1.26
1.1
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
47
347
1.37
1.24
1.3
1.4
u/l
7.0
5.8
0.31
36
280
(3004809) Band form neutrophils/100 leukocytes in Blood
25
163
1.54
1.23
1.9
3.9
%
0.6
1.3
1.15
18
140
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
33
229
1.45
1.22
1.6
1.5
u/ml
114.4
122.5
—
10
44
(3014271) Vancomycin [Susceptibility]
10
49
2.05
1.22
2.4
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
35
246
1.43
1.22
1.8
2.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
19
2.64
1.21
1.8
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
213
1.47
1.21
3.4
3.3
e9/l
4.9
4.2
0.79
31
213
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
32
223
1.45
1.17
3.4
3.6
%
59.5
56.8
0.71
32
223
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
110
1.65
1.15
1.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
110
1.65
1.15
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
110
1.65
1.15
1.2
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
106
881
1.22
1.15
2.3
4.6
%
0.8
0.9
0.29
33
271
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
36
0.00
1.14
0.0
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
36
0.00
1.14
0.0
5.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
135
1151
1.19
1.13
2.0
2.5
ug/g
156.4
158.0
0.01
113
954
(3017446) Testosterone [Moles/volume] in Serum or Plasma
178
1554
1.17
1.13
2.2
2.4
nmol/l
13.3
13.6
0.24
146
1396
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
42
311
1.36
1.11
1.1
1.3
g/l
0.2
0.2
0.16
36
296
(3044941) Cell count panel - Synovial fluid
26
176
1.49
1.10
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
160
1.51
1.09
1.1
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
112
1.62
1.09
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
66
1.83
1.09
3.9
3.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
105
879
1.21
1.08
3.8
3.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
74
1.76
1.07
1.4
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
97
1.66
1.07
2.0
4.3
%
62.1
55.3
0.55
11
73
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
67
1.80
1.05
1.0
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1025
9972
1.13
1.04
35.2
14.8
%
38.8
41.3
18.10
705
7412
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
22
2.28
1.03
1.0
1.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
150
0.53
1.03
1.1
1.1
—
4.5
—
0
9
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1027
10529
0.89
1.02
4.5
4.0
mmol/l
1.7
1.4
3.98
944
9780
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
151
1315
1.17
1.01
11.9
7.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
181
1.45
0.98
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
49
1.84
0.98
1.4
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
13
212
0.61
0.98
4.8
3.1
mmol/l
9.0
7.5
0.78
13
206
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
50
1.81
0.96
2.4
2.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
225
1.39
0.95
1.2
1.4
iu/l
14.7
21.7
0.93
22
184
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
51
1.77
0.94
3.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
45
576
0.77
0.93
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
167
1.45
0.92
1.2
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
26
184
1.42
0.92
2.2
2.6
—
3.5
—
0
6
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
28
2.15
0.91
1.0
3.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
29
210
1.39
0.91
1.2
1.2
—
397.1
—
0
7
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
253
0.67
0.88
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
35
264
1.33
0.86
1.4
1.6
e6/l
15766.7
15535.4
0.01
27
193
(4094501)
26
356
0.72
0.86
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
64
1.72
0.86
3.2
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
433
1.26
0.86
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
16
104
1.55
0.84
1.2
1.3
—
36.0
—
0
5
(3044290) Cell count panel - Cerebral spinal fluid
30
222
1.36
0.84
1.2
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
10
57
1.76
0.83
4.3
5.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
97
830
1.18
0.83
2.4
4.7
%
0.1
0.1
0.67
28
245
(3025130) Human papilloma virus identified in Specimen
8
46
1.74
0.82
2.1
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
97
1.55
0.81
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
47
1.71
0.80
1.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
41
321
1.29
0.80
1.1
1.3
g/l
1.3
1.2
1.16
35
306
(3017732) Neutrophils [#/volume] in Blood
82
695
1.19
0.79
3.8
3.3
e9/l
4.9
4.2
1.62
60
556
(3035320) C reactive protein [Mass/volume] in Body fluid
11
66
1.67
0.78
2.4
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
74
1.63
0.78
2.3
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
226
1.34
0.76
1.4
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
59
1.70
0.76
1.6
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
10
59
1.70
0.76
1.1
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
67
1.65
0.75
1.0
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
150
1.41
0.73
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
55
1.64
0.73
1.1
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
219
0.68
0.73
2.2
3.7
mg/l
18.7
27.1
—
8
136
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
242
0.70
0.73
1.0
1.2
—
2.9
—
0
20
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
56
1.61
0.72
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
686
6606
1.08
0.72
3.1
2.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
93
805
1.17
0.71
2.3
4.4
%
0.5
0.5
0.01
23
200
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
126
1.43
0.70
1.1
1.5
—
—
—
0
0
(44790049)
19
135
1.41
0.69
1.3
1.6
—
—
—
0
0
(44806118)
19
135
1.41
0.69
1.3
1.6
—
—
—
0
0
(44790048)
19
135
1.41
0.69
1.3
1.6
—
—
—
0
0
(44790047)
19
135
1.41
0.69
1.3
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
227
0.70
0.68
3.4
4.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
43
1.63
0.67
1.3
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
28
1.79
0.66
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
128
1.41
0.66
1.1
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
128
1.41
0.66
1.1
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
143
1287
1.12
0.65
4.9
4.4
%
30.7
30.6
0.03
110
896
(3022621) pH of Urine by Test strip
69
590
1.18
0.63
2.2
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
165
1502
1.11
0.62
1.5
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
182
1.32
0.61
1.2
1.2
u/ml
1.6
3.5
—
7
68
(4306422)
24
183
1.32
0.59
1.3
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
44.8
—
0
22
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
31
246
1.27
0.58
1.2
1.3
e6/l
13.3
42.5
0.60
21
192
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
31
246
1.27
0.58
1.2
1.4
e6/l
10.0
910.8
1.05
22
199
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
179
1643
1.10
0.58
1.3
1.3
iu/ml
34.5
34.1
0.01
44
513
(3024471) HLA-A [Type]
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
0
23
0.00
0.58
0.0
1.8
—
138.3
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
175
1.32
0.58
1.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
55
1.46
0.56
1.1
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
55
1.46
0.56
1.1
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
55
1.46
0.56
1.1
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
125
0.64
0.54
1.4
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
12
82
1.47
0.54
1.6
2.3
min
461.2
502.0
—
5
55
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
12
82
1.47
0.54
1.0
1.4
mmol/l
2.0
2.0
0.13
12
76
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.0
2.4
ug/l
2.5
1.0
—
6
33
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
57
488
1.18
0.54
1.4
2.0
u/l
41.9
39.4
0.37
51
435
(3024263) Appearance of Synovial fluid
9
62
1.45
0.53
1.4
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
91
1.43
0.53
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
100
0.60
0.51
1.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
135
1.34
0.51
1.3
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
629
6488
0.94
0.51
4.1
4.4
ug/l
1.9
2.3
0.91
545
5902
(40768806) Pleura Pathology biopsy report
16
118
1.36
0.50
1.4
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
41
1.47
0.50
1.2
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
127
1.34
0.49
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
244
1.23
0.48
1.1
1.3
miu/ml
225.8
216.6
—
6
101
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
93
1.40
0.48
2.7
1.5
g/l
1.0
1.0
0.12
13
93
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.0
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
102
1.38
0.47
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
199
0.75
0.46
1.0
1.2
—
1.5
—
0
11
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1149
11610
0.92
0.46
36.6
16.5
umol/l
81.3
83.0
0.75
1149
11605
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
50
1.40
0.45
1.0
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
50
1.40
0.45
1.1
1.6
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
7
51
1.37
0.44
1.0
1.3
%
—
1.9
—
0
8
(40768443) Skin Pathology biopsy report
50
433
1.16
0.43
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
247
2335
1.07
0.43
3.6
4.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
911
9268
0.94
0.42
40.2
17.7
g/l
333.6
334.5
2.14
905
9217
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
93
0.64
0.42
21.7
16.0
nmol/l
1135.5
1413.0
—
6
93
(44806420)
5
33
1.52
0.41
1.8
2.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
0.6
—
0
8
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
105
1.34
0.41
1.5
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
41
352
1.17
0.40
1.1
1.2
—
1.1
—
0
28
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
123
1.30
0.40
1.3
2.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
123
1.30
0.40
1.0
1.5
%
64.9
61.3
—
8
79
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
60
1.34
0.40
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
88
1.37
0.40
1.3
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
103
0.68
0.39
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
196
1.23
0.39
2.6
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
115
1.31
0.39
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
124
1.29
0.38
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
160
1.25
0.38
3.0
2.6
—
—
—
0
0
(4027681)
9
66
1.37
0.38
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
136
0.73
0.37
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
37
1.35
0.37
9.6
6.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
37
1.35
0.37
1.2
1.3
ug/l
11.8
9.2
—
5
37
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
407
0.86
0.37
1.3
1.8
mg/l
10.2
4.6
0.54
25
289
(4024509)
9
70
1.29
0.36
1.7
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
123
0.73
0.35
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
126
1.27
0.35
2.3
2.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1060
10479
1.06
0.35
5.7
4.5
mmol/l
7.0
6.1
26.65
961
9647
(3008037) Lactate [Moles/volume] in Venous blood
18
222
0.81
0.34
3.8
3.1
mmol/l
2.1
1.5
0.56
18
214
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
181
1.22
0.34
1.2
1.2
u/ml
5.4
5.3
—
7
87
(3051593) INR in Capillary blood by Coagulation assay
6
44
1.37
0.34
1.0
15.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
85
778
1.10
0.34
2.5
4.8
%
0.0
0.1
1.57
23
212
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
53
474
1.12
0.32
2.4
3.5
pmol/l
4.4
4.6
0.61
43
428
(3000330) Specific gravity of Urine by Test strip
39
442
0.88
0.31
3.5
3.2
—
—
—
0
0
(4035726)
95
880
1.09
0.30
1.5
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
120
1.25
0.30
1.1
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
184
0.81
0.28
1.6
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
121
1.24
0.28
1.4
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
375
0.88
0.28
1.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.27
1.4
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.27
1.4
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.27
1.4
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.27
1.4
2.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
34
299
1.14
0.27
1.3
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
71
0.70
0.26
2.4
2.0
ug/l
3.1
1.9
—
5
62
(3026470) Cobalt [Mass/volume] in Blood
5
72
0.69
0.26
2.4
2.0
ug/l
5.3
3.2
—
5
65
(3013139) Helicobacter pylori Ag [Presence] in Stool
67
618
1.09
0.25
1.2
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
13
105
1.24
0.25
1.6
2.3
ml
873.7
655.9
—
6
63
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
137
0.80
0.24
1.7
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
133
1.21
0.24
1.3
2.1
—
—
—
0
0
(4034850)
31
349
0.89
0.24
8.6
9.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
161
1538
1.05
0.23
1.2
1.2
u/ml
1.7
10.6
6.52
36
630
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
316
0.88
0.22
1.3
1.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
219
1.14
0.22
1.2
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
11.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
2.7
—
0.2
—
0
12
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
101
0.79
0.21
1.1
1.3
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
25.8
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
9.3
—
0.3
—
0
14
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
48
1.25
0.20
1.2
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
48
1.25
0.20
1.2
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
49
1.23
0.20
1.5
1.3
ug/l
11.2
6.9
—
6
43
(3036071) Salmonella sp Ab [Titer] in Serum
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
114
0.79
0.20
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
127
1.18
0.19
1.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
5.7
7.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
51
1.18
0.19
2.5
4.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
21
184
1.14
0.19
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
109
1.19
0.18
1.0
1.3
%
25.7
26.6
—
6
71
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
128
1.17
0.18
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
128
1.17
0.18
1.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
60
1.17
0.17
1.1
2.9
—
—
—
0
0
(3017704) Immunofixation for Urine
5
67
0.75
0.17
1.2
1.4
—
—
—
0
0
(3036603) Volume of Urine
8
69
1.16
0.16
1.5
1.5
—
1708.1
—
0
15
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
182
0.88
0.15
2.4
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
140
1.14
0.15
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
46
492
0.93
0.15
1.0
1.2
iu/ml
78.8
156.2
1.08
12
181
(4268621)
11
129
0.85
0.14
2.5
2.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
129
0.85
0.14
1.3
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
7
86
0.81
0.14
2.4
3.1
—
39.3
—
0
26
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
86
0.81
0.14
1.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
112
1.16
0.14
1.2
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
170
0.88
0.13
1.1
1.4
pmol/l
92.6
228.4
—
6
56
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
132
1.14
0.13
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
138
0.87
0.13
1.5
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
271
2765
0.97
0.13
3.7
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
37
392
0.94
0.10
1.8
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
55
575
0.95
0.10
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
34
360
0.94
0.09
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
184
1.09
0.09
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
6
56
1.07
0.08
2.7
2.4
umol/l
73.5
53.2
—
6
50
(44813793)
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
58
1.03
0.08
1.0
2.5
u/l
148.2
199.9
—
6
58
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
1.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
7
67
1.05
0.08
1.7
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
73
0.82
0.07
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
27
286
0.94
0.07
1.6
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
82
0.85
0.07
1.0
1.2
—
94.4
—
0
5
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
24
255
0.94
0.07
1.0
1.2
—
10.8
—
0
10
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17
183
0.93
0.06
1.0
1.1
—
33.6
—
0
13
(40761511) CBC panel - Blood by Automated count
1126
11234
1.02
0.06
29.6
13.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
50
488
1.03
0.03
2.1
2.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
113
1145
0.99
0.03
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
192
1.04
0.02
1.1
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
39
399
0.98
0.02
1.1
1.1
—
82.3
—
0
9
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1159
11601
0.99
0.02
21.1
10.4
u/l
33.1
30.5
3.20
1128
11265
(3005570) Glucose [Moles/volume] in Urine
11
103
1.07
0.02
1.6
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
62
611
1.02
0.02
1.2
1.3
u/ml
457.6
274.1
0.95
56
563
(3042631) Mycobacterium sp identified in Specimen
16
167
0.96
0.01
1.9
2.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
134
1.05
0.00
1.0
1.1
u/ml
2.9
2.3
—
6
60
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
102
0.98
0.00
1.4
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
418
1.00
0.00
2.3
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
390
3896
1.00
0.00
4.4
3.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
52
0.96
0.00
1.4
2.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
9
98
0.92
0.00
2.2
2.3
—
40.7
—
0
12
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
59
0.85
0.00
1.0
1.2
iu/ml
119.4
212.9
—
5
59
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
5.1
—
403.3
—
0
9
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.4
—
0
5
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.4
2.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
68
0.88
0.00
1.3
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.1
—
0
7
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
7.3
—
0
7
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.2
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
7
76
0.92
0.00
1.1
1.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.4
2.4
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044336) Cobalt [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
14.2
—
0
6
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
2.1
—
0.8
—
0
9
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
95
0.95
0.00
1.0
1.3
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
0.1
—
0
7
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
70.5
—
0
6
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.4
—
831.1
—
0
7
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
2.0
—
0
5
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
79
1.01
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ALCOPANCACU and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ALCOPANCACU | 4.5 [2.55, 7.94] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.196 |
During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 815 females with ALCOPANCACU died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ALCOPANCACU | 3.965 [3.18, 4.95] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 456 out of 3511 males with ALCOPANCACU died.
Mortality risk
Mortality risk for people of age
years, who have ALCOPANCACU.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.291% | 0.681% |
| 5 | 3.029% | 4.904% |
| 10 | 6.421% | 12.006% |
| 15 | 12.055% | 21.085% |
| 20 | 20.524% | 33.046% |
Relationships between endpoints
↥Index endpoint: ALCOPANCACU – Alcohol-induced acute pancreatitis
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data